These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1678853)

  • 1. Comparisons of the combined contributions of agonist binding frequency and intrinsic efficiency to receptor-mediated activation of adenylate cyclase.
    Stickle D; Barber R
    Mol Pharmacol; 1991 Aug; 40(2):276-88. PubMed ID: 1678853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the role of epinephrine binding frequency in activation of adenylate cyclase.
    Stickle D; Barber R
    Mol Pharmacol; 1989 Sep; 36(3):437-45. PubMed ID: 2550777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of receptor-mediated activation of GTP-binding protein/adenylate cyclase using the encounter coupling model.
    Stickle D; Barber R
    Mol Pharmacol; 1993 Mar; 43(3):397-411. PubMed ID: 8095693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound beta adrenergic receptors.
    Contreras ML; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1986 Apr; 237(1):154-64. PubMed ID: 2870174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta adrenergic receptor subtypes in the atria: evidence for close coupling of beta-1 and beta-2 adrenergic receptors to adenylate cyclase.
    Liang BT; Molinoff PB
    J Pharmacol Exp Ther; 1986 Sep; 238(3):886-92. PubMed ID: 2875173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The encounter coupling model for beta-adrenergic receptor/GTP-binding protein interaction in the S49 cell. Calculation of the encounter frequency.
    Stickle D; Barber R
    Biochem Pharmacol; 1992 May; 43(9):2015-28. PubMed ID: 1350723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists.
    Hoyer D; Reynolds EE; Molinoff PB
    Mol Pharmacol; 1984 Mar; 25(2):209-18. PubMed ID: 6142414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ethanol in vitro on the beta adrenergic receptor-coupled adenylate cyclase system.
    Bode DC; Molinoff PB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1040-7. PubMed ID: 2843625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desensitization and resensitization of beta-adrenergic receptors in a smooth muscle cell line.
    Scarpace PJ; Baresi LA; Sanford DA; Abrass IB
    Mol Pharmacol; 1985 Dec; 28(6):495-501. PubMed ID: 2867463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of beta-2 adrenergic receptors of high coupling efficiency in human neutrophil sonicates.
    Galant SP; Allred SJ
    J Lab Clin Med; 1980 Jul; 96(1):15-23. PubMed ID: 6248606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. II. Agonist binding to soluble beta adrenergic receptors.
    Contreras ML; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1986 Apr; 237(1):165-72. PubMed ID: 2870175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding and functional characteristics of beta adrenergic receptors in the intact neutrophil.
    Galant SP; Allred S
    J Lab Clin Med; 1981 Aug; 98(2):227-37. PubMed ID: 6265572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization of adenylate cyclase and down regulation of beta adrenergic receptors after in vivo administration of beta agonist.
    Scarpace PJ; Abrass IB
    J Pharmacol Exp Ther; 1982 Nov; 223(2):327-31. PubMed ID: 6127402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system.
    Waelbroeck M; Taton G; Delhaye M; Chatelain P; Camus JC; Pochet R; Leclerc JL; De Smet JM; Robberecht P; Christophe J
    Mol Pharmacol; 1983 Sep; 24(2):174-82. PubMed ID: 6136901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenergic receptors, cyclic AMP, and ion transport in the avian erythrocyte.
    Aurbach GD; Spiegel AM; Gardner JD
    Adv Cyclic Nucleotide Res; 1975; 5():117-32. PubMed ID: 165661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered adrenergic response and specificity of the receptors in rat ascites hepatoma AH130.
    Sanae F; Miyamoto K; Koshiura R
    Cancer Res; 1989 Nov; 49(22):6242-6. PubMed ID: 2553251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes.
    Costa T; Klinz FJ; Vachon L; Herz A
    Mol Pharmacol; 1988 Dec; 34(6):744-54. PubMed ID: 2849042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis.
    Zaremba TG; Fishman PH
    Mol Pharmacol; 1984 Sep; 26(2):206-13. PubMed ID: 6207420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists.
    Neve KA; Barrett DA; Molinoff PB
    J Pharmacol Exp Ther; 1985 Dec; 235(3):657-64. PubMed ID: 2867205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homologous desensitization of the beta-adrenergic receptor. Functional integrity of the desensitized receptor from mammalian lung.
    Strasser RH; Cerione RA; Codina J; Caron MG; Lefkowitz RJ
    Mol Pharmacol; 1985 Sep; 28(3):237-45. PubMed ID: 2993846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.